Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 12:56 pm Sale | 2022-07-11 | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital World Investors | 0 0.000% | -12,509 (Position Closed) | Filing History |
| 2022-02-11 6:06 pm Sale | 2021-12-31 | 13G | QUINCE THERAPEUTICS, INC QNCX | PFIZER INC PFE | 3,000 2.010% | -7,282 (-70.82%) | Filing History |
| 2022-02-11 2:48 pm Sale | 2022-02-14 | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital World Investors | 12,509 8.400% | -3,345 (-21.10%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital Research Global Investors | 0 0.000% | -13,029 (Position Closed) | Filing History |
| 2021-12-10 4:09 pm Unchanged | 2021-12-10 | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital International Investors | 7,312 4.900% | 0 (Unchanged) | Filing History |
| 2021-12-10 2:34 pm Sale | 2021-12-10 | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital International Investors | 7,312 4.900% | -7,570 (-50.87%) | Filing History |
| 2021-10-08 12:10 pm Unchanged | 2021-10-12 | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital International Investors | 14,882 10.000% | 0 (Unchanged) | Filing History |
| 2021-10-08 12:03 pm Purchase | 2021-10-12 | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital International Investors | 14,882 10.000% | 1,980 (+15.35%) | Filing History |